The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKakuzi Regulatory News (KAKU)

Share Price Information for Kakuzi (KAKU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 92.50
High: 0.00
Low: 0.00
Prev. Close: 92.50
KAKU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

3 Aug 2016 07:00

RNS Number : 0481G
Kakuzi Ld
03 August 2016
 

KAKUZI LIMITED

 

 

EXTRACT FROM THE INTERIM FINANCIAL STATEMENTS

FOR THE PERIOD OF SIX MONTHS TO 30 JUNE 2016

 

The unaudited results for the Kakuzi Group for the period of six months to 30 June 2016 and the comparative figures for the previous year are as follows:

 

Condensed Consolidated Statement of Comprehensive Income

 

30 June 2016

Restated

30 June 2015

Shs'000

Shs'000

Sales

437,347

420,173

(Loss)/Profit before fair value gain in Biological assets and income tax

(109,297

)

(33,858

)

Fair value gain in Biological assets

57,693

37,411

(Loss)/Profit before income tax

(51,604

)

3,553

Income tax credit/(expense)

16,366

(1,117

)

(Loss)/Profit for the period

(35,238

)

2,436

Other Comprehensive Income

-

-

Total comprehensive (Loss)/income

(35,238

)

2,436

Total comprehensive (loss)/income attributable to

equity holders of the company:

(35,238

)

2,436

Shs

Shs

Earnings per share attributable to equity holders of the company:

Basic and diluted earnings per stock unit

(1.80

)

0.12

Condensed Consolidated Statement of Financial Position

Restated

Restated

30 June 2016

30 June 2015

31 December 2015

Shs'000

Shs'000

Shs'000

EQUITY

Share capital

98,000

98,000

98,000

Other reserves

8,936

3,981

8,936

Retained earnings

3,135,304

2,811,683

3,170,542

Proposed dividends

-

-

98,000

Total equity

3,242,240

2,913,664

3,375,478

Non-current liabilities

699,444

699,653

712,787

3,941,684

3,613,317

4,088,265

REPRESENTED BY

Non-current assets

2,922,894

2,676,157

2,833,891

Current assets

634,409

503,175

448,150

Cash and cash balances

731,663

665,083

1,175,434

Current liabilities

(347,282

)

(231,098

)

(369,210

)

Net current assets

1,018,790

937,160

1,254,374

3,941,684

3,613,317

4,088,265

 

Overview:

 

The above is an extract from the interim financial statements which have been prepared in accordance with the International Financial Reporting Standards (IFRS).

 

The company has fully adopted the amendments to the International Accounting Standard (IAS) 41 - Agriculture and our permanent plantings are now classified under IAS 16 - property, plant and equipment as bearer plants to be depreciated over their expected useful life. This has resulted in the original reported profit before tax for the six month period to 30th June 2015 of Ksh 63.8 million being restated to Ksh 3.5 million.

The loss before tax for the period under review is Ksh 51.6 million. This somewhat disappointing result has been mainly due to lower tea prices, lower livestock sales and the delay of macadamia sales due to awaiting completion of the cracking facility construction.

To predict financial performance for the year is impossible at this stage with the irregularities of supply and demand together with exchange rates to contend with.

 

The Directors do not recommend the payment of an Interim Dividend.

 

 

BY ORDER OF THE BOARD

 

K W TARPLEE

CHAIRMAN

02 August 2016

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BLGDIXBGBGLD
12
Date   Source Headline
20th Mar 20248:27 amRNSAnnual Financial Report
6th Dec 20237:00 amRNSProfit Warning Announcement
25th Aug 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSAnnual Financial Report
19th Aug 20227:00 amRNSHalf-year Report
23rd Mar 20227:00 amRNSAnnual Financial Report
6th Jan 20227:00 amRNS2021 PROFIT WARNING ANNOUNCEMENT
18th Aug 20217:00 amRNSHalf-year Report
22nd Mar 20217:00 amRNSAnnual Financial Report - Replacement
19th Mar 20217:00 amRNSAnnual Financial Report
2nd Nov 20207:00 amRNSDirectorate Change
19th Aug 20207:00 amRNSHalf-year Report
26th May 20207:00 amRNSAGM Statement
9th Apr 20207:00 amRNSDividend Declaration
20th Mar 20207:00 amRNSAnnual Financial Report
19th Feb 20207:00 amRNSDeath Of Director
15th Aug 20197:00 amRNSHalf-year Report
29th Mar 20197:00 amRNSAnnual Financial Report
15th Aug 20187:00 amRNSHalf-year Report
23rd Mar 20187:00 amRNSAnnual Financial Report
7th Aug 20177:00 amRNSHalf-year Report
29th Mar 20177:00 amRNSDirectorate Change
29th Mar 20177:00 amRNSAnnual Financial Report
3rd Aug 20167:00 amRNSDirectorate Change
3rd Aug 20167:00 amRNSHalf-year Report
17th Mar 20167:00 amRNSAnnual Financial Report
12th Aug 20157:00 amRNSHalf Yearly Report
27th May 20157:00 amRNSDirectorate Change
25th Mar 20157:00 amRNSAnnual Financial Report
27th Aug 20147:00 amRNSHalf Yearly Report
19th Mar 20147:00 amRNSFinal Results
27th Nov 20137:00 amRNSPROFIT WARNING
27th Aug 20137:00 amRNSHalf Yearly Report
2nd Apr 20137:00 amRNSDirectorate Change
2nd Apr 20137:00 amRNSAnnual Financial Report
30th Nov 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSProfit Warning Announcement
31st Aug 20127:00 amRNSInterim Financial Statements
22nd Aug 20127:00 amRNSDisposal
2nd Apr 20127:00 amRNSFinal results for the year ended 31 Dec 2011
7th Feb 20127:00 amRNSPublic Announcement
30th Aug 20117:11 amRNSHalf Yearly Report
18th Mar 20118:03 amRNSFinal Results 2010 Replacement
18th Mar 20117:39 amRNSFinal Results 2010
26th Jan 20117:00 amRNSPublic Announcement
25th Aug 20104:55 pmRNSHalf Yearly Report
12th Mar 20107:00 amRNSFinal Results
26th Aug 20097:00 amRNSHalf Yearly Report
5th Mar 20094:21 pmRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.